Suppr超能文献

钙通道阻滞剂的作用机制。

Mechanisms of action of calcium entry blockers.

作者信息

Godfraind T

出版信息

Fed Proc. 1981 Dec;40(14):2866-71.

PMID:7308497
Abstract

This review is focused on experimental observations that permit conclusions about the mechanism of action of calcium entry blockers. It is shown that studies on the blockade of contraction (or relaxation) of depolarized smooth muscle must be confirmed by direct estimates of calcium fluxes. Superimposition of dose-inhibition curves of contraction and 45Ca entry are a prerequisite for allowing a drug to be regarded as a specific calcium entry blocker. Among the main characteristics of such drugs are their tissue selectivity and use dependency in depolarized preparations. It is shown that one of these (flunarizine) interacts with binding sites located in the plasma membrane possibly associated with the calcium channels. The physiological role of calcium and possible therapeutic uses of calcium entry blockers are also summarized.

摘要

本综述聚焦于那些能得出钙通道阻滞剂作用机制结论的实验观察结果。研究表明,关于去极化平滑肌收缩(或舒张)阻滞的研究必须通过对钙通量的直接评估来证实。收缩剂量 - 抑制曲线与45Ca内流的叠加是一种药物被视为特异性钙通道阻滞剂的前提条件。这类药物的主要特性包括其组织选择性以及在去极化制剂中的使用依赖性。研究表明,其中一种药物(氟桂利嗪)与位于质膜上可能与钙通道相关的结合位点相互作用。文中还总结了钙的生理作用以及钙通道阻滞剂可能的治疗用途。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验